# Pharmapod

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pharmapod

- Industry: Software
- Headquarters: Dublin, Ireland
- Website: www.pharmapodhq.com
- Total disclosed funding: $1M
- Latest round: Seed (Aug 1, 2014)
- Investors on record: 3

## About

Pharmapod Ltd. specializes in cloud-based medication incident management solutions, enhancing safety and compliance for healthcare professionals through systematic documentation and analysis of medication-related incidents.Founded in 2011 and headquartered in Dublin, Ireland, Pharmapod Ltd. develops a medication incident management platform designed for healthcare professionals. The company was acquired by Think Research Corporation in November 2021 for approximately USD 1 mn. Pharmapod has successfully completed 5 deals and has raised a total of USD 1.90 mn through its funding rounds, with the latest being an Add-on round. The founder's prior history and other ventures are not publicly documented.Pharmapod's core offering is a cloud-based medication incident management platform that enhances patient safety and compliance for healthcare professionals. This platform provides users with the ability to document and analyze medication-related incidents for effective root-cause analysis. Features include real-time data analytics, customizable reports, and streamlined documentation, catering to a diverse range of clients including pharmacies, care homes, hospitals, and healthcare organizations across North America, Europe, Australia, and New Zealand.Pharmapod generates revenue primarily through subscription-based transactions with healthcare facilities utilizing its medication safety platform. Clients subscribe to access various tailored modules, including incident documentation and quality improvement tools. Furthermore, Pharmapod collaborates with healthcare organizations to integrate its services, ensuring compliance with regulatory requirements across regions such as the United States, Canada, the United Kingdom, Australia, and the European Union.Following its acquisition in November 2021, Pharmapod plans to increase its offerings by expanding its network of international clinicians. The recent funding will support the development and launch of new products aimed at enhancing their platform capabilities. The company is targeting expansion into new geographic markets, although specific regions and timelines have not been disclosed.

## Funding rounds

- Seed, Aug 1, 2014, $1M — Enterprise Ireland, Furthr, NDRC

## Investors

- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Seed
- Furthr (https://capitalatlas.ai/funds/furthr) — Seed
- NDRC — Seed